<?xml version='1.0' encoding='UTF-8'?>
<PolymerNanocomposite><PDB_ID>4BGH</PDB_ID><DATA_SOURCE><Citation><CitationType>research article</CitationType><Publication>ChemMedChem</Publication><Title>The Lab Oddity Prevails: Discovery of Pan-CDK Inhibitor ( R )- S -Cyclopropyl- S -(4-{[4-{[(1 R ,2 R )-2-hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide (BAY&amp;#8197;1000394) for the Treatment of Cancer</Title><Author>Lücking, Ulrich</Author><Author>Jautelat, Rolf</Author><Author>Krüger, Martin</Author><Author>Brumby, Thomas</Author><Author>Lienau, Philip</Author><Author>Schäfer, Martina</Author><Author>Briem, Hans</Author><Author>Schulze, Julia</Author><Author>Hillisch, Alexander</Author><Author>Reichel, Andreas</Author><Author>Wengner, Antje Margret</Author><Author>Siemeister, Gerhard</Author><Publisher>Wiley Blackwell (John Wiley &amp; Sons)</Publisher><PublicationYear>2013</PublicationYear><DOI>10.1002/cmdc.201300096</DOI><Volume>8</Volume><Issue>7</Issue></Citation></DATA_SOURCE><MATERIALS><Matrix><MatrixComponent><ChemicalName>Cyclin-dependent kinase 2</ChemicalName><MacroMoleculeClass>TRANSFERASE</MacroMoleculeClass><MacroMoleculeType>Protein</MacroMoleculeType><ManufacturerOrSourceName>Homo sapiens</ManufacturerOrSourceName><MolecularWeight><value>34378.75</value></MolecularWeight></MatrixComponent></Matrix></MATERIALS><CHARACTERIZATION><XRay_Diffraction_and_Scattering><Equipment>ESRF ADSC CCD</Equipment><Description>Data collection temperature: 100 K, Resolution: 1.95</Description></XRay_Diffraction_and_Scattering></CHARACTERIZATION><PROPERTIES><Biological><Sequence>MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL</Sequence><SpaceGroup>P 21 21 21</SpaceGroup></Biological></PROPERTIES></PolymerNanocomposite>